These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3545789)

  • 41. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term clinical effects of antidepressive agents].
    Sechter D
    Encephale; 1995 Mar; 21 Spec No 2():35-8. PubMed ID: 7588177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium potentiation of antidepressant treatment.
    Louie AK; Meltzer HY
    J Clin Psychopharmacol; 1984 Dec; 4(6):316-21. PubMed ID: 6511998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment resistance in unipolar depression: Is it an iatrogenic phenomenon caused by antidepressant treatment of patients with a bipolar diathesis?
    Sharma V
    Med Hypotheses; 2006; 67(5):1142-5. PubMed ID: 16797856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Long-term treatment with antidepressive drugs].
    Lôo H; Brochier T
    Ann Med Psychol (Paris); 1995 May; 153(3):190-6; discussion 196-7. PubMed ID: 7598353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lithium in the treatment of refractory depression].
    Brochier T; Pascalis JG; Lôo H
    Encephale; 1993; 19(5):553-64. PubMed ID: 8306924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of lithium to augment antidepressant medication.
    Rouillon F; Gorwood P
    J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetic factors and resistance to antidepressant treatment].
    Vandel B; Vandel S
    Encephale; 1986 Oct; 12 Spec No():217-22. PubMed ID: 3545788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The treatment of severe, therapy-resistant depression using infusions of antidepressants].
    Pöldinger W; Dirnhofer-Bertolini E
    Schweiz Rundsch Med Prax; 1989 Feb; 78(8):188-90. PubMed ID: 2922514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent aspects of biological treatment of depression].
    Pöldinger W
    Ther Umsch; 1990 Mar; 47(3):233-40. PubMed ID: 1971120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The treatments of manic-depressive psychosis].
    Kodama H; Watanabe S
    Nihon Rinsho; 1994 May; 52(5):1208-12. PubMed ID: 8007390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating refractory depression.
    Standish-Barry H
    Int Clin Psychopharmacol; 1990 Jul; 5 Suppl 3():33-43. PubMed ID: 2230071
    [No Abstract]   [Full Text] [Related]  

  • 55. Sleep deprivation therapy in depression.
    Svendsen K
    Acta Psychiatr Scand; 1976 Sep; 54(3):184-92. PubMed ID: 970195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fever caused by metapramine. Diagnosis of fever caused by psychotropic drugs].
    Le Jeunne C; Plaisant O; Henslik V; Hugues FC
    Ann Med Interne (Paris); 1988; 139(1):29-30. PubMed ID: 3364875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose tricyclics potentiation with mirtazapine, lithium and partial sleep-deprivation: why not tricyclics in combination strategies for resistant melancholia?
    Espárrago-Llorca G; Carrión-Expósito L; Hans-Chacón A; Ruiz-Doblado S
    Ther Adv Psychopharmacol; 2012 Feb; 2(1):31-3. PubMed ID: 23983953
    [No Abstract]   [Full Text] [Related]  

  • 58. Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics.
    Levy A; El-Hage W; Bennabi D; Allauze E; Bouvard A; Camus V; Courtet P; Dorey JM; Etain B; Fond G; Genty JB; Holtzmann J; Horn M; Leboyer M; Llorca PM; Meyrel M; Molière F; Nguon AS; Petrucci J; Rey R; Richieri R; Stephan F; Vaiva G; Walter M; Haffen E; Aouizerate B; Yrondi A
    Front Psychiatry; 2021; 12():795666. PubMed ID: 34938218
    [No Abstract]   [Full Text] [Related]  

  • 59. [Good and bad therapeutic combinations in the treatment of resistant depressions].
    Poirier MF; Benkelfat C
    Encephale; 1986 Oct; 12 Spec No():225-30. PubMed ID: 3545789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report on efficacy of treatments for bipolar disorder.
    Gelenberg AJ; Hopkins HS
    Psychopharmacol Bull; 1993; 29(4):447-56. PubMed ID: 8084977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.